Senior Scientist – Biophysics at Illumina

Singapore, Singapore, Singapore

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, GenomicsIndustries

Requirements

PhD in biophysics, bioengineering, biochemistry, protein chemistry or related field
0-5 years of post-PhD hands-on experience with DNA-related biophysics experiments, DNA processing enzymes, or method development for DNA sequencing
Understanding of single molecule biophysics; interdisciplinary experience combining biochemistry and biophysics to address biological problems
Familiarity and comfort working with data collection systems, interpreting data sets, and troubleshooting experiments
Exceptional data interpretation skills and ability to study data to propose next steps
Highly creative and inventive problem solver with a can-do attitude
Excellent communication and presentation skills
Highly collaborative team player

Responsibilities

Design, execute and interpret single molecule experiments, utilizing an understanding of DNA, enzymes and biophysics
Effectively work within multidisciplinary and international teams and routinely interact with synthetic chemists, protein chemists, bioinformatics scientists, and engineers to solve problems and devise experimental plans
Innovate and devise creative solutions to difficult biophysics problems
Keep detailed lab notebooks, prepare reports, updates, and summaries for managers and team
Write technical reports and prepare presentations for cross functional and cross-site technical teams

Skills

Biophysics

Single-molecule experiments

DNA

Polymerases

Helicases

Scripting

Programming

Instrumentation troubleshooting

Biochemistry

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free